AVAllegra Via

Allegra Via

*This is an algorithmically generated author record based on publicly available information.

Allegra Via has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fast, Comprehensive, and User Customizable Macromolecule Interface Analysis with FACE2FACE

    by Patrizio Di Micco, Mario Incarnato, Gianmarco Pascarella, Allegra Via, Veronica Morea

    Structural analysis of interfaces in macromolecular complexes is crucial to unveiling the mechanisms underlying molecular recognition. While several valuable computational tools exist for interface analysis, many web-based tools have limitations in input types, analysis comprehensiveness, or output customization, and there remains a need for an immediately accessible solution requiring no software installation, especially for users with limited computational skills. We have developed FACE2FACE, a user-friendly, fast, and comprehensive tool available as a web server for macromolecule interface analysis. FACE2FACE analyzes interfaces between proteins, nucleic acids, and other biological macromolecules or small molecules, providing extensive information that can be instantly visualized on the server interface and easily downloaded. The downloaded materials comprise files in formats that can be easily parsed and imported in spreadsheet applications as customizable contact maps and scripts to quickly visualize interface features in widely used applications such as PyMol and ChimeraX. Examples of FACE2FACE contributions to research projects are described.


  • Open Access

    Structural Analysis of the SARS‐CoV‐2 Spike N‐Terminal Domain Across Wild‐Type and Recent Variants: A Comparative Study

    by Miriana Quaranta, Allegra Via, Stefano Pascarella

    Since its first appearance in China, the molecular evolution of SARS‐CoV‐2 has progressed through altering the properties of the Spike protein, changing the virus ability to transmit and to evade host immune surveillance. Despite receiving less attention than the Receptor Binding Domain (RBD), the Spike N‐Terminal Domain (NTD) is crucial to SARS‐CoV‐2 biology and pathogenesis. This study provides a comparative structural analysis of the NTD from the wild‐type strain and different variants (BA.2, XBB.1, XBB.1.5, BA.2.86, JN.1, HV.1, KP.2, KP.3, and KP.3.1.1), aiming to clarify the structural impact of mutations in each variant. To assess the impact of mutations on the interaction of NTD with antibodies, we selected as a test case the neutralizing antibody 4A8, which has proven highly effective against the WT. The results obtained from molecular dynamics simulations, surface electrostatic potential analysis, and binding energy predictions show a clear trend in the evolution of the virus. The net charge of the NTD decreases as the variants progress, reaching a minimum charge of −1.84 observed for KP.3.1.1. This is in clear contrast to the RBD net charge, which follows an opposite trend toward higher positive values. Binding energy predictions show that the antibody's efficacy decreases as the virus evolves. While the WT exhibited an interaction energy of −96.28 kcal/mol with 4A8, more recent variants like KP.3 show no interaction stronger than −64.00 kcal/mol. These results reveal a clear trend of modifications aimed at favoring immune escape in the virus' evolutionary trajectory.


  • Open Access

    The ELIXIR-EXCELERATE Train-the-Trainer pilot programme: empower researchers to deliver high-quality training

    by Sarah L Morgan, Patricia M Palagi, Pedro L Fernandes, Eija Koperlainen, Jure Dimec, Diana Marek, Lee Larcombe, Gabriella Rustici, Teresa K Attwood, Allegra Via

    One of the main goals of the ELIXIR-EXCELERATE project from the European Union’s Horizon 2020 programme is to support a pan-European training programme to increase bioinformatics capacity and competency across ELIXIR Nodes. To this end, a Train-the-Trainer (TtT) programme has been developed by the TtT subtask of EXCELERATE’s Training Platform, to try to expose bioinformatics instructors to aspects of pedagogy and evidence-based learning principles, to help them better design, develop and deliver high-quality training in future. As a first step towards such a programme, an ELIXIR-EXCELERATE TtT (EE-TtT) pilot was developed, drawing on existing ‘instructor training’ models, using input both from experienced instructors and from experts in bioinformatics, the cognitive sciences and educational psychology. This manuscript describes the process of defining the pilot programme, illustrates its goals, structure and contents, and discusses its outcomes. From Jan 2016 to Jan 2017, we carried out seven pilot EE-TtT courses (training more than sixty new instructors), collaboratively drafted the training materials, and started establishing a network of trainers and instructors within the ELIXIR community. The EE-TtT pilot represents an essential step towards the development of a sustainable and scalable ELIXIR TtT programme. Indeed, the lessons learned from the pilot, the experience gained, the materials developed, and the analysis of the feedback collected throughout the seven pilot courses have both positioned us to consolidate the programme in the coming years, and contributed to the development of an enthusiastic and expanding ELIXIR community of instructors and trainers.